GHENT, Belgium, Jan. 4, 2018 /PRNewswire/ — ActoBio Therapeutics, Inc., a wholly owned subsidiary of Intrexon Corporation (NYSE: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today announced that Pieter…
